Home Prices Weakened in June, But Were Still Much Higher Than a Year Ago, Says S&P Case-Shiller
"There have been multiple false starts for anointing beverages the next big thing," Tharp said."But I think we've gotten to a point where we are showing that the year over year growth is something that is substantial." There are experts who worry such higher-dose THC in drinks could pose serious health risks. Despite cannabis beverage brands often being touted for their wellness benefits or for being hangover free, there has been a a lack of government-funded research about them."THC can increase the risk of paranoia, anxiety, and even psychosis and hallucinations," said Charles Michael White, department head of the University of Connecticut's School of Pharmacy.
"There's not a lot of research that can be performed on it because cannabis is a schedule one drug in the U.S.," he said, adding that this is one of the main roadblocks keeping the industry from joining the mainstream more quickly. In addition to limiting research, today's federal cannabis prohibition means cannabis beverage makers are largely operating under a patchwork of state laws, creating a disjointed supply chain. This keeps many companies from growing in a significant way, which has led to some pulling back on their efforts in the market and others giving up completely.associated with manufacturing CBD and THC beverages.